Alyeska Investment Group’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-52,767	Closed	-$867K	–	509
2015 Q3	$867K	Buy	52,767 +2,746	+5%	+$45.1K	0.01%	393
2015 Q2	$1.12M	Sell	50,021 -74,979	-60%	-$1.68M	0.01%	378
2015 Q1	$1.22M	Buy	+125,000	New	+$1.22M	0.02%	394